22 March

AJKD https://www.ajkd.org/

• 00:00
  Epidemiology of Community-Acquired Acute Kidney Injury Among US Veterans - Clarissa J. Diamantidis, Lindsay Zepel, Valerie A. Smith, M. Alan Brookhart, Erin Burks, C. Barrett Bowling, Matthew L. Maciejewski, Virginia Wang AJKD
  Community-acquired acute kidney injury (CA-AKI) develops outside of the hospital and is the most common form of AKI globally. National estimates of CA-AKI in the US are absent due to limited availability of lab data. This study leverages national data from the Veterans Health Administration (...) (American Journal of Kidney Diseases (2023))

Nature Reviews Nephrology http://www.nature.com/ncpneph/

• 00:00
  Intradialytic acute brain injury - Ellen F. Carney Nature Reviews Nephrology
  Nature Reviews Nephrology, Published online: 22 March 2023; doi:10.1038/s41581-023-00708-xIntradialytic acute brain injury (Nature Reviews Nephrology, Published online: 2023-03-22; | doi:10.1038/s41581-023-00708-x)

Br Med J (BMJ) http://www.bmj.com/

• 15:56
  Big Macs and the Beano: Authors’ reply to correspondence - Claire Mulrenan, Mark Petticrew Br Med J (BMJ)
  We reply to the correspondence to our article on whether it is time for the Beano to drop junk food brands.1In his rapid response, Freshwater suggests that the Beano’s reliance on foods that are high in fat, sugar, and salt for quiz content simply reflects readership preferences.2 He correctly (...)
• 15:51
  Safeguarding the equitable distribution of resources - Daniel J Chivers Br Med J (BMJ)
  Salisbury reflects on a complaint she received after bringing to a close a lengthy consultation with a patient.1 Her humble conclusion was that she could have been kinder.The equitable distribution of resources is an element of justice, one of the pillars of medical ethics.2 GP consultations (...)

J Human Hypertens http://www.nature.com/jhh/

• 00:00
  Is more better? The impact of implementing more interventions for hypertension control in a practice facilitation study for small- and medium-sized practices - Samuel M. Ross, Andrew Wang, Lauren Anthony, Stephen D. Persell, Jingzhi Yu, Abel N. Kho J Human Hypertens
  Journal of Human Hypertension, Published online: 22 March 2023; doi:10.1038/s41371-023-00813-1Is more better? The impact of implementing more interventions for hypertension control in a practice facilitation study for small- and medium-sized (...) (Journal of Human Hypertension, Published online: 2023-03-22; | doi:10.1038/s41371-023-00813-1)

Br Med J (BMJ) http://www.bmj.com/

• 12:26
  Supermarket plastic bags and NHS demand management - Santhanam Sundar Br Med J (BMJ)
  The NHS is struggling and lurching from one crisis to another because it is underfunded compared with its peers in the western world.1 Demand in the NHS is currently managed indiscriminately and haphazardly through scarcity of GP appointments, long emergency department waiting times, delays in (...)
• 11:31
  Allelujah: A starry love letter to the NHS - Alison Shepherd Br Med J (BMJ)
  bmj;380/mar22_4/p665/FAF1faPathé UKJudi Dench, Derek Jacobi, Jennifer Saunders, and Russell Tovey are among the stars of a film that aims to pay tribute to the deep humanity of NHS staff battling with limited resources and ever growing demand.Allelujah, which is based on the Alan Bennett play, (...)
• 10:51
  John Launer: When good things happen in bad times - John Launer Br Med J (BMJ)
  I’ve had a very inspiring week. Firstly, I taught a group of second year medical students who are doing a special study module on the future of general practice. Many of them already intend to become GPs and are excited by what specialist generalism can offer.The following day I took part in an (...) -- General practice / family medicine, UK
• 10:41
  Junior doctors strike: What consultants learnt from holding the fort - Emma Wilkinson Br Med J (BMJ)
  While thousands of junior doctors picketed outside hospitals last week during the three day strike action, consultants and other members of the team held the fort, in some cases doing tasks they hadn’t done for a decade or more. On one level the NHS did keep running, patients were seen, (...) -- UK
• 10:11
  UK GPs are more stressed than international peers, analysis shows - Gareth Iacobucci Br Med J (BMJ)
  General practitioners in the UK are experiencing the highest stress and lowest job satisfaction when compared with colleagues in nine other high income countries, an analysis has found.The report by the Health Foundation analysed data from the Commonwealth Fund’s survey of 9526 GPs in 10 high (...) -- General practice / family medicine, UK

J Am Heart Assoc https://www.ahajournals.org/feeds.jsp

• 11:28
  Sans titre J Am Heart Assoc

J Clin Hypertens http://onlinelibrary.wiley.com//journal/10.1111/(ISSN)1751-7176

• 07:44
  Nocturnal blood pressure surge in seconds is associated with arterial stiffness independently of conventional nocturnal blood pressure variability in suspected obstructive sleep apnea patients - Ayako Kokubo, Mitsuo Kuwabara, Naoko Tomitani, Shingo Yamashita, Toshikazu Shiga, Kazuomi Kario J Clin Hypertens
  The Journal of Clinical Hypertension, EarlyView. -- SHORT RESEARCH ARTICLE (Wiley: The Journal of Clinical Hypertension: Table of Contents)

Kidney Int http://www.kidney-international.org/

• 00:00
  DNA binding protein YB-1 is a part of the neutrophil extracellular trap mediation of kidney damage and cross-organ effects. - Jialin Wang, Xiyang Liu, Yulu Gu, Yingying Gao, Vera Jankowski, Nina Was, Anna Leitz, Lucy K. Reiss, Yiqin Shi, Jieru Cai, Yi Fang, Nana Song, Shuan Zhao, Jürgen Floege, Tammo Ostendorf, Xiaoqiang Ding, Ute Raffetseder Kidney Int
  Open-heart surgery is associated with high morbidity, with acute kidney injury (AKI) being one of the most commonly observed postoperative complications. Following open-heart surgery, in an observational study we found significantly higher numbers of blood neutrophils in a group of 13 patients (...) (Kidney International (2023))
• 00:00
  Novel MUC1 variant identified by massively parallel sequencing explains interstitial kidney disease in a large Dutch family - Amber de Haan, Albertien M. van Eerde, Mark Eijgelsheim, Patrick Rump, Bert van der Zwaag, Eric Hennekam, Martina Živná, Stanislav Kmoch, Anthony J. Bleyer, Kendrah Kidd, Liffert Vogt, Nine V.A.M. Knoers, Martin H. de Borst Kidney Int
  Chronic kidney disease (CKD) can be caused by various systemic and kidney disorders with overlapping or nonspecific clinical presentations. Despite a thorough diagnostic workup, the primary cause of CKD remains uncertain in 20% to 35% of affected individuals.1,2 Recent studies have demonstrated (...) (Kidney International (2023))

Lancet Diab Endocrinol https://www.thelancet.com/journals/landia/home

• 02:14
  [Comment] Biodiversity and its double-edged role in the pathogenesis of type 1 diabetes - Daniel Chan, Jan Hau Lee Lancet Diab Endocrinol
  Over the past decade, research into the mechanistic pathways and causal factors of type 1 diabetes has revealed increasing complexity in its pathogenesis. The immune system is a key mediator between the genomics of an individual who is susceptible to type 1 diabetes and the immediate (...) (The Lancet Diabetes & Endocrinology 11, 4 (2023))
• 02:14
  [Correspondence] Long-term association between homelessness and mortality among people with diabetes - Kathryn Wiens, Li Bai, Peter C Austin, Paul E Ronksley, Stephen W Hwang, Eldon Spackman, Gillian L Booth, David J T Campbell Lancet Diab Endocrinol
  People experiencing homelessness with diabetes face many barriers to care and self-management, including a lack of control over meal options or eating schedules, not having a safe place to store medications, and difficulties navigating the health-care system.1 Consequently, such situations put (...) (The Lancet Diabetes & Endocrinology 11, 4 (2023))
• 02:14
  [Corrections] Correction to Lancet Diabetes Endocrinol 2020; 8: 490–500 Lancet Diab Endocrinol
  Ferrara A, Hedderson MM, Brown SD, et al. A telehealth lifestyle intervention to reduce excess gestational weight gain in pregnant women with overweight or obesity (GLOW): a randomised, parallel-group, controlled trial. Lancet Diabetes Endocrinol 2020; 8: 490–500—The appendix of this Article has (...) (The Lancet Diabetes & Endocrinology 11, 4 (2023))
• 02:14
  [Articles] SARS-CoV-2 and type 1 diabetes in children in Finland: an observational study - Mikael Knip, Anna Parviainen, Maaret Turtinen, Anna But, Taina Härkönen, Jussi Hepojoki, Tarja Sironen, Rommel Iheozor-Ejiofor, Hasan U?urlu, Kalle Saksela, Johanna Lempainen, Jorma Ilonen, Olli Vapalahti, Finnish Pediatric Diabetes Register Lancet Diab Endocrinol
  Children and adolescents diagnosed with type 1 diabetes during the pandemic had a more severe disease at diagnosis. The observed increase in type 1 diabetes incidence during the first 18 months could be a consequence of lockdown and physical distancing rather than a direct effect of SARS-CoV-2 (...) (The Lancet Diabetes & Endocrinology 11, 4 (2023))

21 March

BMC Nephrol https://www.biomedcentral.com/bmcnephrol/

• 01:00
  The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally - Sudesh Hariparshad, Rajendra Bhimma, Louansha Nandlal, Edgar Jembere, Saraladevi Naicker and Alain Assounga BMC Nephrol
  Chronic kidney disease (CKD) is a globally significant non-communicable disorder. CKD prevalence varies between countries and within a country. We compared the prevalence rates of CKD in South Africa with sub-... -- Research

Diabetologia http://link.springer.com/

• 00:00
  Racial difference in the association between non-alcoholic fatty liver disease and incident type 2 diabetes: findings from the CARDIA study Diabetologia
  Abstract Aims/hypothesis Type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) are prevalent diseases of metabolic origin. We examined the association between NAFLD and the development of type 2 diabetes among non-Asian adults, and whether the association differs by race. Methods We (...)

Hypertension https://www.ahajournals.org/

• 10:00
  Effect of Cyclooxygenase Inhibition on Peripheral Venous Distension Reflex in Healthy Humans - Takuto Hamaoka Urs A. Leuenberger Anthony Kronfli Zhaohui Gao Cheryl Blaha Jonathan Carter Luck Paul Dalton Lawrence I. Sinoway Jian Cui Penn State Heart and Vascular Institute, Pennsylvania State University College of Medicine, Hershey. Hypertension
  Hypertension, Ahead of Print. Background:Peripheral venous distension evokes a pressor reflex (venous distension reflex). Afferent group III and IV nerves innervating veins are suggested as the afferent arm of the venous distension reflex. Prostaglandins stimulate/sensitize group III/IV nerves. (...) (Hypertension)

J Am Heart Assoc https://www.ahajournals.org/feeds.jsp

• 11:45
  Comparative Effects of Mineral Oil, Corn Oil, Eicosapentaenoic Acid, and Docosahexaenoic Acid in an In Vitro Atherosclerosis Model - Samuel C. R. Sherratt, Peter Libby , Deepak L. Bhatt , and R. Preston Mason 1 Department of Molecular, Cellular, and Biomedical Sciences University of New Hampshire Durham NH USA 2 Elucida Research LLC Beverly MA USA 3 Department of Medicine, Cardiovascular Division, Brigham and Women’s Hospital Harvard Medical School Boston MA USA 4 Mount Sinai Heart Icahn School of Medicine at Mount Sinai New York NY USA J Am Heart Assoc
  Journal of the American Heart Association, Ahead of Print. (Journal of the American Heart Association)
• 11:45
  Noninvasive Hemodynamic Evaluation Following TAVI for Severe Aortic Stenosis - Tzlil Grinberg, Yaron Aviv , Mordehay Vaturi , Leor Perl , Maya Wiessman , Hanna Vaknin?Assa , Pablo Codner , Yaron Shapira , Ran Kornowski , and Katia Orvin 1 Department of Cardiology Rabin Medical Center Petah Tikva Israel 2 The Faculty of Medicine Tel Aviv University Tel Aviv Israel J Am Heart Assoc
  Journal of the American Heart Association, Ahead of Print. BackgroundVarious hemodynamic changes occur following transcatheter aortic valve implantation (TAVI) that may impact therapeutic decisions. NICaS is a noninvasive bioimpedance monitoring system aimed at hemodynamic assessment. We used (...) (Journal of the American Heart Association)
• 11:45
  Cerebral and Retinal Infarction in Bicuspid Aortic Valve - Geoffrey D. Huntley, Hector I. Michelena , Jeremy J. Thaden , Adham K. Alkurashi , Sorin V. Pislaru , Alberto Pochettino , Juan A. Crestanello , Joseph J. Maleszewski , Robert D. Brown , and Vuyisile T. Nkomo 1 Department of Cardiovascular Medicine Mayo Clinic Rochester MN 2 Department of Surgery Jefferson Health – Abington PA Abington 3 Department of Cardiovascular Surgery Mayo Clinic Rochester MN 4 Department of Laboratory Medicine and Pathology Mayo Clinic Rochester MN 5 Department of Neurology Mayo Clinic Rochester (...) J Am Heart Assoc
  Journal of the American Heart Association, Ahead of Print. BackgroundDescription of cerebral and retinal infarction in patients with bicuspid aortic valve (BAV) is limited to case reports. We aimed to characterize cerebral and retinal infarction and examine outcomes in patients with BAV.Methods (...) (Journal of the American Heart Association)
• 11:44
  Use of Nonrecommended Drugs in Patients With Brugada Syndrome: A Danish Nationwide Cohort Study - Camilla H. B. Jespersen, Johanna Krøll , Priya Bhardwaj , Carl Johann Hansen , Jesper Svane , Bo G. Winkel , Christian Jøns , Peter Karl Jacobsen , Jens Haarbo , Jens Cosedis Nielsen , Jens Brock Johansen , Berit T. Philbert , Sam Riahi , Christian Torp?Pedersen , Lars Køber , Jacob Tfelt Hansen , and Peter E. Weeke 1 Department of Cardiology, The Heart Centre Copenhagen University Hospital, Rigshospitalet København Denmark 2 Department of Cardiology Copenhagen University Hospital ? Herlev and Gentofte Hellerup Denmark 3 Department of Cardiology Aarhus University Hospital Aarhus Denmark 4 (...) J Am Heart Assoc
  Journal of the American Heart Association, Ahead of Print. BackgroundPatients with Brugada syndrome (BrS) are recommended to avoid drugs that may increase their risk of arrhythmic events. We examined treatment with such drugs in patients with BrS after their diagnosis.Methods and ResultsAll (...) (Journal of the American Heart Association)
• 11:44
  Mechanical Cardiopulmonary Resuscitation During In?Hospital Cardiac Arrest - Oscar J. L. Mitchell, Xinyi Shi , Benjamin S. Abella , and Saket Girotra 1 Division of Pulmonary, Allergy, and Critical Care, Department of Medicine University of Pennsylvania Philadelphia PA USA 2 Department of Emergency Medicine, Center for Resuscitation Science Philadelphia PA USA 3 Leonard Davis Institute of Health Economics, University of Pennsylvania Philadelphia PA USA 4 Division of Cardiovascular Medicine, Department of Internal Medicine University of Texas Southwestern Medical Center Dallas TX (...) J Am Heart Assoc
  Journal of the American Heart Association, Ahead of Print. (Journal of the American Heart Association)
• 11:44
  Thiamine for the Treatment of Cardiac Arrest–Induced Neurological Injury: A Randomized, Blinded, Placebo?Controlled Experimental Study - Lauge Vammen, Cecilie Munch Johannsen , Cecilie Dahl Baltsen , Casper Nørholt , Mark Eggertsen , Signe Mortensen , Lasse Vormefenne , Amalie Povlsen , Michael W. Donnino , Bo Løfgren , Lars W. Andersen , and Asger Granfeldt 1 Department of Anesthesiology and Intensive Care Aarhus University Hospital Aarhus Denmark 2 Department of Clinical Medicine Aarhus University Aarhus Denmark 3 Department of Cardiothoracic Anesthesia Copenhagen University Hospital, Rigshospitalet Risskov Denmark 4 Center for Resuscitation Science, Department of Emergency Medicine Beth Israel Deaconess Medical Center (...) J Am Heart Assoc
  Journal of the American Heart Association, Ahead of Print. BackgroundThiamine supplementation has demonstrated protective effects in a mouse model of cardiac arrest. The aim of this study was to investigate the neuroprotective effects of thiamine in a clinically relevant large animal cardiac (...) (Journal of the American Heart Association)
• 11:43
  Circ?myh8 Promotes Pulmonary Hypertension by Recruiting KAT7 to Govern Hypoxia?Inducible Factor?1? Expression - Yan Xing, Jing Qi , Xiaohan Cheng , Xinyue Song , Jingya Zhang , Songyue Li , Xiaoting Zhao , Ting Gong , Jiaxin Yang , Chong Zhao , Wei Xin , Daling Zhu , and Xiaodong Zheng 1 Department of Pharmacology Harbin Medical University–Daqing Daqing Heilongjiang China 2 School of Pharmacy Harbin Medical University–Daqing Daqing Heilongjiang China 3 College of Pharmacy, Harbin Medical University Harbin China 4 Department of Medical Genetics Harbin Medical University–Daqing Daqing Heilongjiang China 5 Library of Harbin Medical University–Daqing Daqing Heilongjiang China 6 Central Laboratory of Harbin (...) J Am Heart Assoc
  Journal of the American Heart Association, Ahead of Print. BackgroundAberrant expression of circular RNAs (circRNAs) contributes to the initiation and progression of pulmonary hypertension (PH). Hypoxia?inducible factor (HIF) is a well?known modulator of hypoxia?induced PH. The role and underlying (...) (Journal of the American Heart Association)
• 11:43
  Outcomes of Investigating T Wave Inversion With Echocardiography in an Unselected Young Male Preparticipation Cohort - Wilbert H. H. Ho, Daniel Y. Z. Lim , Nishanth Thiagarajan , Hankun Wang , Wesley T. W. Loo , Gerald G. R. Sng , Joshua S. W. Lee , Xiayan Shen , Mayank Dalakoti , Ching?Hui Sia , Benjamin Y. Q. Tan , Huai Yang Lim , Luo?Kai Wang , Weien Chow , Terrance S. J. Chua , Paul C. Y. Lim , Tee Joo Yeo , and Daniel T. T. Chong 1 Medical Classification Centre Central Manpower Base, Singapore Armed Forces Singapore Singapore 2 Department of Cardiology National Heart Centre Singapore Singapore Singapore 3 Department of Cardiology National University Heart Centre Singapore Singapore Singapore 4 (...) J Am Heart Assoc
  Journal of the American Heart Association, Ahead of Print. BACKGROUNDElectrocardiography (ECG) may be performed as part of preparticipation sports screening. Recommendations on screening of athletes to identify individuals with previously unrecognized cardiac disease are robust; however, data (...) (Journal of the American Heart Association)
• 11:42
  Infarct?Related Artery as a Donor of Collaterals in ST?Segment–Elevation Myocardial Infarction With Concomitant Chronic Total Occlusion: Challenge of the Double?Jeopardy Thesis - Matthias Scholz, Thomas Meyer , Lars S. Maier , and Karl Heinrich Scholz 1 Department of Diagnostic and Interventional Radiology University Medical Center Göttingen Göttingen Germany 2 Department of Psychosomatic Medicine and Psychotherapy University Medical Center Göttingen Göttingen Germany 3 German Centre for Cardiovascular Research (DZHK) partner site Göttingen Göttingen Germany 4 Department of Internal Medicine II University Hospital Regensburg Regensburg Germany 5 Department of Cardiology and Intensive Care St. Bernward Hospital Hildesheim (...) J Am Heart Assoc
  Journal of the American Heart Association, Ahead of Print. BACKGROUNDIn ST?segment–elevation myocardial infarction (STEMI), a concomitant chronic total occlusion (CTO) in a non–infarct?related artery (NIRA) is associated with adverse outcome. In the case of the infarct?related artery (IRA) as a (...) (Journal of the American Heart Association)
• 11:42
  Correction to: Association of Incidentally Discovered Covert Cerebrovascular Disease Identified Using Natural Language Processing and Future Dementia J Am Heart Assoc
  Journal of the American Heart Association, Ahead of Print. (Journal of the American Heart Association)
• 10:14
  Locking the Revolving Door: Racial Disparities in Cardiovascular Disease - Gladys Velarde, Katia Bravo?Jaimes , Eric J. Brandt , Daniel Wang , Paul Douglass , Luis R. Castellanos , Fatima Rodriguez , Latha Palaniappan , Uzoma Ibebuogu , Rachel Bond , Keith Ferdinand , Gina Lundberg , Ritu Thaman , Krishnaswami Vijayaraghavan , and Karol Watson 1 Department of Cardiology University of Florida Jacksonville FL 2 Division of Cardiology University of California Los Angeles CA 3 Division of Cardiology University of Michigan Ann Arbor MI 4 Division of Cardiology Wellstar Atlanta Medical Center Atlanta GA 5 Division of Cardiovascular Medicine University of California (...) J Am Heart Assoc
  Journal of the American Heart Association, Ahead of Print. Racial disparities in cardiovascular disease are unjust, systematic, and preventable. Social determinants are a primary cause of health disparities, and these include factors such as structural and overt racism. Despite a number of (...) (Journal of the American Heart Association)
• 10:13
  Cardiovascular Risk Prediction in Men and Women Aged Under 50 Years Using Routine Care Data - Hendrikus J. A. van Os, Jos P. Kanning , Tobias N. Bonten , Margot M. Rakers , Hein Putter , Mattijs E. Numans , Ynte M. Ruigrok , Rolf H. H. Groenwold , and Marieke J. H. Wermer 1 Department of Neurology Leiden University Medical Center Leiden The Netherlands 2 National eHealth Living Lab Leiden University Medical Center Leiden The Netherlands 3 Department of Public Health & Primary Care Leiden University Medical Center Leiden The Netherlands 4 Department of Biomedical Data Sciences Leiden University Medical Center Leiden The Netherlands 5 Department of Clinical Epidemiology UMC Utrecht (...) J Am Heart Assoc
  Journal of the American Heart Association, Ahead of Print. BackgroundPrediction models for risk of cardiovascular events generally do not include young adults, and cardiovascular risk factors differ between women and men. Therefore, this study aimed to develop prediction models for first?ever (...) (Journal of the American Heart Association)
• 10:13
  Convolution Neural Network Algorithm for Shockable Arrhythmia Classification Within a Digitally Connected Automated External Defibrillator - Christine P. Shen, Benjamin C. Freed , David P. Walter , James C. Perry , Amr F. Barakat , Ahmad Ramy A. Elashery , Kevin S. Shah , Shelby Kutty , Michael McGillion , Fu Siong Ng , Rola Khedraki , Keshav R. Nayak , John D. Rogers , and Sanjeev P. Bhavnani 1 Division of Cardiology Healthcare Innovation Laboratory Scripps Clinic San Diego CA 2 Carnegie Mellon University Pittsburgh PA 3 Massachusetts Institute of Technology Cambridge MA 4 University of California San Diego, Rady Children’s Hospital San Diego CA 5 University of Pittsburg Medical Center Pittsburgh PA 6 Charleston Area Medical (...) J Am Heart Assoc
  Journal of the American Heart Association, Ahead of Print. BackgroundDiagnosis of shockable rhythms leading to defibrillation remains integral to improving out?of?hospital cardiac arrest outcomes. New machine learning techniques have emerged to diagnose arrhythmias on ECGs. In out?of?hospital (...) (Journal of the American Heart Association)
• 10:12
  Correction to: Disrupted Blood–Brain Barrier and Mitochondrial Impairment by Autotaxin–Lysophosphatidic Acid Axis in Postischemic Stroke J Am Heart Assoc
  Journal of the American Heart Association, Ahead of Print. (Journal of the American Heart Association)

Circulation http://ahajournals.org/

• 07:27
  Letter by Deng et al Regarding Article, “Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study” - Liling Deng Yan Chen Wuquan Deng Department of Endocrinology and School of Medicine, Chongqing University Central Hospital, Chongqing Emergency Medical Center, Chongqing 400014, China. Circulation
  Circulation, Volume 147, Issue 12, Page 985-986, March 21, 2023. (Circulation)
• 07:27
  Letter by Schmidt et al Regarding Article, “Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study” - Maria Inês Schmidt Paula A. Bracco Bruce B. Duncan Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. Circulation
  Circulation, Volume 147, Issue 12, Page 987-987, March 21, 2023. (Circulation)
• 07:27
  Response by Tabák et al to Letters Regarding Article, “Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study” - Adam G. Tabák Naveed Sattar Mika Kivimäki Brain Sciences, University College London, United Kingdom (A.G.T., M.K.). Department of Internal Medicine and Oncology (A.G.T.), Semmelweis University Faculty of Medicine, Budapest, Hungary. Department of Public Health (A.G.T.), Semmelweis University Faculty of Medicine, Budapest, Hungary. School of Cardiovascular and Metabolic Health, University of Glasgow, United Kingdom (N.S.). Clinicum, Faculty of Medicine, University of Helsinki, Finland (...) Circulation
  Circulation, Volume 147, Issue 12, Page 988-989, March 21, 2023. (Circulation)
• 07:27
  Highlights From the Circulation Family of Journals Circulation
  Circulation, Volume 147, Issue 12, Page 977-981, March 21, 2023. (Circulation)
• 07:27
  Adult Congenital Heart Disease: A Specialty With Ever-Expanding Challenges - Eric Rosenthal Shakeel A. Qureshi Department of Paediatric and Adult Congenital Heart Disease, Evelina London Children’s Hospital, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK. Circulation
  Circulation, Volume 147, Issue 12, Page 939-941, March 21, 2023. (Circulation)
• 07:27
  Don’t Break the Axis: Placental Inflammation Leads to Congenital Heart Disease - José Luis de la Pompa Intercellular Signaling in Cardiovascular Development & Disease Laboratory, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain. Ciber de Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Madrid, Spain. Circulation
  Circulation, Volume 147, Issue 12, Page 973-976, March 21, 2023. (Circulation)
• 07:00
  Supervised Exercise Training for Chronic Heart Failure With Preserved Ejection Fraction: A Scientific Statement From the American Heart Association and American College of Cardiology - Vandana Sachdev Kavita Sharma Steven J. Keteyian Charina F. Alcain Patrice Desvigne-Nickens Jerome L. Fleg Viorel G. Florea Barry A. Franklin Maya Guglin Martin Halle Eric S. Leifer Gurusher Panjrath Emily A. Tinsley Renee P. Wong Dalane W. Kitzman Circulation
  Circulation, Ahead of Print. Heart failure with preserved ejection fraction (HFpEF) is one of the most common forms of heart failure; its prevalence is increasing, and outcomes are worsening. Affected patients often experience severe exertional dyspnea and debilitating fatigue, as well as poor (...) (Circulation)

Stroke https://www.ahajournals.org/

• 10:00
  When Will We Have What We Need to Advise Patients How to Manage Their Carotid Stenosis?: Lessons From SPACE-2 - Thomas G. Brott James F. Meschia Brajesh K. Lal Ángel Chamorro Virginia J. Howard George Howard Department of Neurology, Mayo Clinic, Jacksonville, FL (T.G.B., J.F.M.). Department of Surgery, University of Maryland, Baltimore (B.K.L.). Department of Neurology, Hospital Clinic, Barcelona, Spain (A.C.). Department of Biostatistics, University of Alabama at Birmingham. (G.H.) Department of Epidemiology, University of Alabama at Birmingham. (V.J.H.) Stroke
  Stroke, Ahead of Print. The recently published SPACE-2 trial (Stent-Supported Percutaneous Angioplasty of the Carotid Artery Versus Endarterectomy-2) compared 3 treatments to prevent stroke in patients with asymptomatic carotid stenosis ?70%: (1) carotid endarterectomy plus best medical (...) (Stroke)
• 10:00
  Genetic Susceptibility to Mood Disorders and Risk of Stroke: A Polygenic Risk Score and Mendelian Randomization Study - Jiangming Sun Yan Borné Andreas Edsfeldt Yunpeng Wang Mengyu Pan Olle Melander Gunnar Engström Isabel Gonçalves Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden (J.S., Y.B., A.E., M.P., O.M., G.E., I.G.). Department of Cardiology, Skåne University Hospital, Malmö, Sweden (A.E., I.G.). Wallenberg Center for Molecular Medicine, Lund University, Sweden (A.E.). Lifespan Changes in Bain and Cognition (LCBC), Department of Psychology, University of Oslo, Norway (Y.W., M.P.). Regeneron Genetics Center, Regeneron Pharmaceuticals, Tarrytown, NY., Regeneron Genetics Center Goncalo (...) Stroke
  Stroke, Ahead of Print. BACKGROUND:Mood disorders and strokes are often comorbid, and their health toll worldwide is huge. This study characterizes prognostic and causal roles of mood disorders in stroke.METHODS:We tested if genetic susceptibilities for mood disorders were associated with all (...) (Stroke)
• 10:00
  NOTCH2NLC GGC Repeat Expansion in Patients With Vascular Leukoencephalopathy - Yi-Chu Liao Cheng-Yu Wei Fu-Pang Chang Ying-Tsen Chou Shao-Lun Hsu Chih-Ping Chung Takeshi Mizuguchi Naomichi Matsumoto Shaw-Fang Yet Yi-Chung Lee Departments of Neurology, National Yang Ming Chao Tung University School of Medicine, Taipei, Taiwan. (Y.-C. Liao, Y.-T.C., S.-L.H., C.-P.C., Y.-C. Lee) Department of Pathology and Laboratory Medicine, National Yang Ming Chao Tung University School of Medicine, Taipei, Taiwan. (F.-P.C.) Taipei Veterans General Hospital, Taiwan. Department of Neurology, National Yang Ming Chao Tung University School of Medicine, Taipei, Taiwan. (Y.-C. Liao, (...) Stroke
  Stroke, Ahead of Print. BACKGROUND:Neuronal intranuclear inclusion disease (NIID), caused by GGC (guanine-guanine-cytosine) repeat expansion inNOTCH2NLC, has several clinical and radiological features akin to cerebral small vessel disease (cSVD). The present study tested the hypothesis (...) (Stroke)

Can J Kidney Health Dis https://journals.sagepub.com/toc/cjka/9

• 06:24
  The Feasibility of a Transitional Care Unit for Patients Newly Started on In-Center Hemodialysis: A Research Letter - Shabnam Hamidi, Sasha Zarnke, Kim Turcotte, Samuel A. Silver Can J Kidney Health Dis
  Canadian Journal of Kidney Health and Disease, Volume 10, Issue , January-December 2023. Background:Patients with end-stage kidney disease face high mortality and morbidity after dialysis initiation. Transitional care units (TCUs) are typically 4- to 8-week structured multidisciplinary programs (...) (Canadian Journal of Kidney Health and Disease)
• 06:14
  Magnitude of the Potential Screening Gap for Fabry Disease in Manitoba: A Population-Based Retrospective Cohort Study - Reid H. Whitlock, Mohammad Nour-Mohammadi, Sarah Curtis, Paul Komenda, Clara Bohm, David Collister, Navdeep Tangri, Claudio Rigatto Can J Kidney Health Dis
  Canadian Journal of Kidney Health and Disease, Volume 10, Issue , January-December 2023. Background:Fabry disease is a rare disorder caused by the deficient activity of ?-galactosidase A (GLA) that often leads to organ damage. Fabry disease can be treated with enzyme replacement or (...) (Canadian Journal of Kidney Health and Disease)

Kidney Int Reports http://www.kireports.org/

• 00:00
  Atypical anti-GBM disease - Joyita Bharati, Yihe Yang, Purva Sharma, Kenar D. Jhaveri Kidney Int Reports
  Atypical anti-GBM disease is characterized by linear immunoglobulin G (IgG) deposition along the glomerular basement membrane (GBM) without circulating IgG anti-GBM antibodies. Compared to classic anti-GBM disease, atypical anti-GBM disease tends to be milder with a more indolent course in (...) (Kidney International Reports (2023))
• 00:00
  d-Asparagine is an ideal endogenous molecule for measuring the glomerular filtration rate - Ayumu Taniguchi, Masataka Kawamura, Shinsuke Sakai, Shihoko Kimura-Ohba, Yoko Tanaka, Shota Fukae, Ryo Tanaka, Shigeaki Nakazawa, Kazuaki Yamanaka, Masaru Horio, Shiro Takahara, Norio Nonomura, Yoshitaka Isaka, Ryoichi Imamura, Tomonori Kimura Kidney Int Reports
  An ideal endogenous molecule for measuring glomerular filtration rate (GFR) is still unknown. However, a rare enantiomer of serine, d-serine, is useful in GFR measurement. This stud explored the potential of other d-amino acids for kidney function (...) (Kidney International Reports (2023))

J Am Med Assoc (JAMA) https://jama.jamanetwork.com/

• 01:00
  Managing Persistent Uncertainty in the Ethics of Clinical Research J Am Med Assoc (JAMA)
  In the face of novel pathogens, incomplete knowledge, and disagreement about the merits of medical treatments, translating the duty to care into concrete benefits for patients depends on our ability to quickly act on the duty to learn. Learning is a dynamic process whose goal, in medical (...)
• 01:00
  At a Higher Dose and Longer Duration, Ivermectin Still Not Effective Against COVID-19 J Am Med Assoc (JAMA)
  A Cochrane meta-analysis of 11 eligible trials examining the efficacy of ivermectin for the treatment of COVID-19 published through April 2022 concluded that ivermectin has no beneficial effect for people with COVID-19. Since May 2022, an additional 3 large randomized clinical trials including (...)
• 01:00
  Higher-Dose Ivermectin vs Placebo and Time to Sustained Recovery in Outpatients With COVID-19 J Am Med Assoc (JAMA)
  This platform randomized clinical trial examines the effectiveness of ivermectin at a targeted dose of 600 ?g/kg daily compared with placebo for the treatment of early mild to moderate COVID-19.
• 01:00
  New Legal Frontiers to Safeguard Reproductive Freedoms J Am Med Assoc (JAMA)
  This Viewpoint summarizes several federal strategies to ensure pregnant persons’ access to abortion services after the recent Supreme Court ruling in Dobbs v Jackson Women’s Health Organization: expanding access to medication abortion, ensuring provision of emergency abortion services, proposing (...)
• 01:00
  Incomplete Information in Table J Am Med Assoc (JAMA)
  In the US Preventive Services Task Force Updated Evidence Report and Systematic Review titled “Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force,” published in the (...)
• 01:00
  Audio Highlights J Am Med Assoc (JAMA)
  Listen to the JAMA Editor’s Audio Summary for an overview and discussion of the important articles appearing in this week’s issue of JAMA.
• 01:00
  Noah Webster as Epidemiologist J Am Med Assoc (JAMA)
  Oct. 16, 1758, there was born, in the best front room of a farmhouse, in the primitive farming village of West Hartford, Conn., a male infant destined to play a very important part in the intellectual development of “these United States of America.” Noah Webster is known today, by name, to every (...)
• 01:00
  Ectopic Pregnancy Risk in Users of Levonorgestrel-Releasing Intrauterine Systems With 52, 19.5, and 13.5 mg of Hormone J Am Med Assoc (JAMA)
  This study assesses the association between use of levonorgestrel intrauterine systems containing 52, 19.5, and 13.5 mg of hormone and ectopic pregnancy in a nationwide cohort study.
• 01:00
  Prevalence and County-Level Distribution of Births in Catholic Hospitals in the US in 2020 J Am Med Assoc (JAMA)
  This study uses American Hospital Association data to examine the volume and distribution of births in Catholic US hospitals and quantify county-level patterns of Catholic and non-Catholic hospital births.
• 01:00
  Preoperative Hemodialysis Timing and Postoperative Mortality in Patients With ESKD J Am Med Assoc (JAMA)
  To the Editor A recent retrospective observational study concluded that longer intervals between hemodialysis and surgery were significantly associated with increased 90-day mortality in Medicare beneficiaries. Although this was a pragmatic analysis of a large cohort, we are concerned that this (...)
• 01:00
  Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Persons J Am Med Assoc (JAMA)
  To the Editor We are disappointed that a recent USPSTF Recommendation Statement failed to recommend menopausal hormone therapy for primary prevention of chronic diseases in postmenopausal persons.
• 01:00
  Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Persons J Am Med Assoc (JAMA)
  To the Editor A recent US Preventive Services Task Force (USPSTF) Recommendation Statement concluded that hormone therapy for postmenopausal persons presents some benefits and extensive risks of harm. Symptom relief therapy was endorsed, but evidence for long-term therapy for prevention of (...)
• 01:00
  Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Persons J Am Med Assoc (JAMA)
  To the Editor The WHI placebo-controlled trial involved 10 739 postmenopausal women with prior hysterectomy, and breast cancer incidence was the primary safety outcome. At 20.3-year follow-up, prior randomized use of conjugated equine estrogen alone was significantly associated with lower (...)
• 01:00
  Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Persons J Am Med Assoc (JAMA)
  To the Editor The USPSTF provides an important service in summarizing the relevant data about preventive interventions, but it was surprising and disheartening to see the updated Evidence Report for the USPSTF hold the WHI menopausal hormone therapy trials in such low regard. Among the many (...)
• 01:00
  Preoperative Hemodialysis Timing and Postoperative Mortality in Patients With ESKD—Reply J Am Med Assoc (JAMA)
  In Reply The Letter from Dr Pal and colleagues about our recent study raises several important points. First, we agree that the ideal exposure would have been the number of hours between the last preoperative hemodialysis session and surgery. Unfortunately, this information was not available in (...)
• 01:00
  Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Persons—Reply J Am Med Assoc (JAMA)
  In Reply Regarding our systematic review on hormone therapy for the primary prevention of chronic conditions in postmenopausal persons, Dr Anderson and Dr Chlebowski and Mr Aragaki express concern about our assessment of the methodological quality of the WHI, which we rated as fair quality or (...)
• 01:00
  Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Persons—Reply J Am Med Assoc (JAMA)
  In Reply In their Letters, Dr Nachtigall and colleagues and Dr Glynne and colleagues note that there may be differences in the benefits and harms of menopausal hormone therapy to prevent chronic conditions based on the age of persons using this treatment or on time since menopause. For its (...)
• 01:00
  Early vs Interval Postpartum Intrauterine Device Placement J Am Med Assoc (JAMA)
  This randomized clinical trial examines the expulsion rate of intrauterine devices placed between 2 to 4 weeks postpartum compared with standard placement timing at 6 to 8 weeks postpartum.
• 01:00
  Mildly Hypercalcemic J Am Med Assoc (JAMA)
  I wonder if it is the slow leaching of ions from their beautiful lattice. As I wake, I trace the aching outline of my bones. Notice first my clavicles Then each fragile vertebra and those hips Step onto the floor and stifle a (...)
• 01:00
  Diagnosis and Treatment of Chronic Lymphocytic Leukemia J Am Med Assoc (JAMA)
  This narrative review discusses the pathophysiology, clinical presentation, and diagnosis, and staging of chronic lymphocytic leukemia and summarizes current treatments.
• 01:00
  JAMA J Am Med Assoc (JAMA)
• 01:00
  Refocusing Cardiovascular Disease Prevention Efforts on Young Adults J Am Med Assoc (JAMA)
  Life expectancy in the US is now the lowest it has been since 1996, with young- and middle-aged adults seeing the most rapid declines. These declines began in 2014 and have accelerated over the past 3 years of the pandemic. While COVID-19 represents a significant proportion, increases in heart (...)
• 01:00
  Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20-44 Years J Am Med Assoc (JAMA)
  This study assesses the prevalence rates of cardiovascular risk factors (hypertension, diabetes, hyperlipidemia, obesity, and tobacco use), treatment, and control among adults aged 20 to 44 years from 2009 through March 2020, overall and by sex and race and (...)
• 01:00
  Listening Lessons J Am Med Assoc (JAMA)
  In this narrative medicine essay, a physician describes the importance of paying attention to the deliberate words patients choose and how physicians must seek to understand why they are chosen rather than translating those words to what they expect to (...)
• 01:00
  Meta-analysis: COVID-19 Infection Protects Against Severe Disease J Am Med Assoc (JAMA)
  Immunity generated by COVID-19 infection protects against hospitalization and death, according to a meta-analysis of 65 studies representing data from 19 countries. Protection against severe disease remained high after 40 weeks, at 90.2% for ancestral, Alpha, and Delta variants and 88.9% for (...)
• 01:00
  Prior COVID-19 Infection Tied to Lasting Lung Abnormalities J Am Med Assoc (JAMA)
  More than one-third of patients hospitalized with COVID-19 had lung abnormalities including scarring and thickening 2 years later, according to an analysis of chest computed tomographic (CT) scans from 144 participants aged 27 to 80 (...)
• 01:00
  Study: Breast Radiotherapy Does Not Improve Survival in Older Patients J Am Med Assoc (JAMA)
  Treatment with radiotherapy alongside breast-conserving surgery and hormone therapy did not improve overall or breast cancer–specific survival, investigators recently reported. It also did not decrease the incidence of distant recurrence as a first event, according to a phase 3 clinical trial (...)
• 01:00
  On-Demand Male Contraceptive Compound Promising in Mouse Study J Am Med Assoc (JAMA)
  A single dose of an experimental compound inactivated sperm in male mice within 30 minutes for up to 2.5 hours and prevented pregnancy in a proof-of-concept study. The researchers also found that the treatment, known as TDI-11861, was safe and did not cause severe adverse effects such as organ (...)
• 01:00
  Chronic Pain at Multiple Sites Tied to Increased Dementia Risk J Am Med Assoc (JAMA)
  Chronic pain, especially at multiple sites in the body, was linked to a higher risk of dementia in a study of more than 350 000 UK Biobank participants aged 39 to 73 years. After adjustments for potential confounders, participants who reported a single site of pain had a 15% higher risk of (...)
• 01:00
  ADHD Drugs in Pregnancy Not Linked to Children’s Brain Development J Am Med Assoc (JAMA)
  After adjusting for maternal confounders, children born to mothers who continued to use attention-deficit/hyperactivity disorder (ADHD) medications during pregnancy were no more likely to have neurodevelopmental disorders than those whose mothers discontinued use, according to a (...)
• 01:00
  Nursing Homes Required to Reveal Ownership Status Under Proposed Rule J Am Med Assoc (JAMA)
  In mid-February, the US Department of Health and Human Services (HHS) announced another step toward strengthening transparency around nursing home ownership. Under the proposed rule, nursing homes enrolled in Medicaid or Medicare would be required to disclose more information about ownership (...)
• 01:00
  Majority of Infant Formula Health Claims Are Poorly Supported J Am Med Assoc (JAMA)
  Manufacturers of most infant formulas claim a range of benefits, such as supporting infants’ brain and eye development, strengthening their immune systems, and easing digestion, based on an analysis of 757 products from 15 countries.
• 01:00
  Patients With Normal Gut Biopsy Still at Increased Risk of IBD J Am Med Assoc (JAMA)
  A normal gastrointestinal (GI) tract biopsy result might not eliminate an inflammatory bowel disease (IBD) diagnosis, according to a population-based, sibling-controlled study published in PLOS Medicine.
• 01:00
  Large Study Finds Women Are (Still) Much More Likely to Die or Have Complications After Coronary Artery Bypass Graft Surgery Than Men J Am Med Assoc (JAMA)
  This Medical News article discusses a new study in JAMA Surgery about outcome differences between women and men after the most common surgical treatment for coronary artery disease.
• 01:00
  Uterine Perforation During Gynecological Procedures J Am Med Assoc (JAMA)
  This article in the Women’s Health series discusses uterine perforation occurring during gynecological procedures, including prevention, identification of risk factors, recognition, management, and long-term outcomes.
• 01:00
  Patient Information: Melanoma J Am Med Assoc (JAMA)
  This JAMA Patient Page describes melanoma, its risk factors, diagnosis, treatment, and prognosis.
• 01:00
  Race-Based Equations Delayed Black Patients From Getting Onto Kidney Transplant Lists—An Unprecedented New Policy Seeks to Undo the Damage J Am Med Assoc (JAMA)
  This Medical News article is an interview about new policy from the US Organ Procurement and Transplantation Network to address the harms of race-based kidney function estimation.
• 01:00
  Time to Abolish Metrics That Sustain Systemic Racism in Kidney Allocation J Am Med Assoc (JAMA)
  This Viewpoint discusses how the Kidney Donor Profile Index (KDPI) in its current form is not fit to guide kidney allocation because it devalues organ donation by Black donors based on a weak association between donor race and kidney transplant (...)
• 01:00
  Redressing the Harms of Race-Based Kidney Function Estimation J Am Med Assoc (JAMA)
  This Viewpoint emphasizes the urgency of abolishing race-based medical practices and explains how they have unjustly contributed to racial inequities in clinical care and health outcomes.

Diabetologia http://link.springer.com/

• 00:00
  Racial difference in the association between non-alcoholic fatty liver disease and incident type 2 diabetes: findings from the CARDIA study Diabetologia
  Abstract Aims/hypothesis Type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) are prevalent diseases of metabolic origin. We examined the association between NAFLD and the development of type 2 diabetes among non-Asian adults, and whether the association differs by race. Methods We (...)

Br Med J (BMJ) http://www.bmj.com/

• 13:26
  The Taliban’s ban on Afghan women attending university is eroding hopes for the future - Ayesha Ahmad, Mohammad Haqmal Br Med J (BMJ)
  An image of a lone 18 year old Afghan woman in Kabul rising up to protest against the Taliban’s ban on Afghan women attending university, revealed a bravery and strength.1On 20 December 2022, the Taliban issued a statement that all Afghan women are banned from attending university. The ban (...)
• 13:06
  John Hawk: global ambassador for photodermatology - John Illman Br Med J (BMJ)
  bmj;380/mar21_9/p662/FAF1fahawk170323.faPhoto credit: Tim HawkJohn Hawk, a charismatic New Zealander, spoke with great affection about his mentor, Ian Magnus, who “spawned in the UK the whole new concept of clinical photobiology.” Magnus developed the skin irradiation monochromator. He was also (...)
• 13:01
  The UK government’s attempt to frighten people into covid protective behaviours was at odds with its scientific advice - Stephen Reicher, John Drury, Susan Michie, Robert West Br Med J (BMJ)
  Among the many revelations from recent leaked UK Government WhatsApp messages published by The Daily Telegraph is the fact that Matt Hancock, former health secretary, proposed using fear in order to get the public to comply with covid-19 restrictions. In December 2020, he wrote that “we must (...)
• 12:46
  Closing the gap in childhood immunisation after the pandemic - Isabelle Munyanga?u, Elisa Lopez–Varela, Quique Bassat Br Med J (BMJ)
  Childhood immunisations are among the most cost effective, equitable, and successful interventions of all times. The World Health Organization’s expanded programme on immunisation has ensured that routine childhood immunisations are available in every country, and vaccination is believed to save (...)
• 12:16
  Food tsar resigns, saying that voters are “fed up” with broken food system - Rebecca Coombes Br Med J (BMJ)
  The government’s food “tsar,” Henry Dimbleby, has resigned from his role to speak openly about the Conservative Party’s failure to reform the food system, a move that he said was essential in stemming the tide of diet related disease in the UK.Dimbleby, an author and restaurateur, was the lead (...) -- General practice / family medicine, UK

AJKD https://www.ajkd.org/

• 10:30
  18 ‘Nectar' Induced Oxalate Nephropathy AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  17 Hot and Muggy Marathon: A Potent Recipe for Rhabdo AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  16 BRASH Syndrome: An Under-Recognized Syndrome in Patients With Renal Failure AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  15 Ghost Toxicity and Acute Kidney Injury AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  14 Understanding Symptoms and Quality-of-Life of Patients With AKI-D AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  13 Distinct Subgroups of Patients Identified-based on Health Utility in Early Acute Kidney Injury Using Latent Class Analysis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  12 Rhabdomyolysis: A Lesser-Known Complication of Hyperosmolar Hyperglycemic Coma AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  11 COVID-19-related Acute Kidney Injury: Incidence, Risk Factors and Outcome in a County Hospital Cohort AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  10 Treatment-Related Cost Analysis for Adults With Hepatorenal Syndrome With Rapid Reduction in Kidney Function AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  9 Overlooked Sulfonamide Induced Nephropathy in Cirrhotic Patients AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  8 Vancomycin-associated Nephrotoxicity AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  7 The Utility of POCUS Enhanced Physical Examination in the Management of Cardiorenal Syndrome AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  6 Hepatorenal Syndrome in a Patient With Fulminant Hepatic Failure From Hepatitis A AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  5 Acute Kidney Injury With Thrombotic Microangiopathy in a Patient With Hemophagocytic Lymphohistiocytosis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  4 Sodium Bicarbonate Use in Severe Rhabdomyolysis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  3 An Uncommon Presentation of Cocaine-Induced Acute Interstitial Nephritis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  2 “Hidden in plAIN sight”: A Case Report AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  1 A Case of AKI in a Patient With Tianeptine Toxicity AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  71 A Unique Case of Membranous Nephropathy and Proteinuria in a Patient With Common Variable Immunodeficiency Syndrome AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  70 Propofol Related Infusion Syndrome With Multifactorial Associated Metabolic Acidosis and Rhabdomyolysis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  69 Prolonged Bile Cast Nephropathy Following Orthotopic Liver Transplant, a Diagnostic and Management Challenge AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  68 Unexplained Hyperphosphatemia in Relapsed AML Patient Undergoing Investigational Therapy. A Diagnostic Enigma AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  67 Ask-Upmark Kidney: A Forgotten Entity AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  66 Hypercalcemia, Tertiary Hyperparathyroidism and Beyond AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  65 Complex ICHD Patient Improves With Tailored Nutrition Regimen AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  64 Successful Rescue of Allograft Kidney via Thrombolysis and Mechanical Thrombectomy After Provoked DVT Causing Anuria AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  63 Rosehip Tea, a Rare Cause of Acute Interstitial Nephritis: A Case Report AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  62 From Soil to the Peritoneum: Fungal Peritonitis With Paecilomyces Variotii AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  61 Transient Proximal Renal Tubular Dysfunction, Fanconi Syndrome, Associated With Salicylate Poisoning AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  60 Collagenofibrotic Glomerulopathy (Collagen Type III Glomerulopathy) Associated With a Bleeding Diathesis: A Case Report AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  59 Calciphylaxis Progressing to Necrotizing Fasciitis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  58 Congophilic Fibrillary Glomerulonephritis: A Case of Natural History AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  57 Infection-related Glomerulonephritis Associated With Campylobacter jejuni Enteritis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  56 Delayed Seropositive Lupus Nephritis: A Clinical Dilemma AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  55 A Case of Syndrome of Inappropriate Mineralocorticoid Excess Secondary to Licorice Toxicity via Over-the-Counter Supplement AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  54 Primary PLA2Rab Positive Membranous Nephropathy With Concomitant Pancreatic Cancer AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  53 Not Every Amyloidosis is Proteinuric: Unusual AL Amyloidosis Deposition AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  52 Do No Harm: Is It Really Idiopathic MPGN? AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  51 An Unusual Kidney Mass: A Hematologic Double Hit AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  50 Hyperleukocytosis, Hyperkalemia and AKI: Tumor Lysis Syndrome, Or Is It? AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  49 Ifosfamide- vs Brentuximab Vedotin-Induced Karyomegalic-like Interstitial Nephritis (KIN)? AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  48 Sjogren’s Nephritis With Glomerular and Tubulointerstitial Disease Responsive to Prednisone AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  47 C3 Glomerulopathy and Thrombotic Microangiopathy: Two Diseases, Same Pathogenesis - A Case Report AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  46 Horseshoe Kidney Complicated by BPH, Recurrent Urinary Tract Infections and Progressive Renal Dysfunction AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  45 Follow-up Post Renal Transplant From Deceased Donor With Gitelman Syndrome AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  44 Acute Interstitial Nephritis Causing Hypokalemia and Diabetes Insipidus AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  43 A Case of Waldenstrom's Macroglobulinemia Causing Type 1 Cryoglobulinemic Glomerulonephritis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  42 Vancomycin-Related Leukocytoclastic Vasculitis With Worsening AKI AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  41 A Rare Case of Acute Kidney Injury (AKI) With IgG-4 Related Disease (RD) Without Extra Renal Manifestations AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  40 Renal Thrombotic Microangiopathy in a Patient With Systemic Lupus Erythematous AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  39 A Subtle Presentation of Acute Interstitial Nephritis With a Peculiar Etiology AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  38 Vancomycin and Piperacillin Induced Acute Interstitial Nephritis in a Patient With Lupus: A Case Report Showcasing Rapid Decline in Renal Function AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  37 Percutaneous Renal Biopsy in a Pregnant Patient: Taking a Different Approach AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  36 A Rare Case of Recurrent UTIs and Hearing Loss Caused by Heterozygous Deletion of GATA 3 Gene AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  35 Abiraterone Acetate, An Unusual Culprit of Severe Hypokalemia, a Case Report AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  34 Outcome Comparison in Hospitalized COVID-19 Patients With and Without AKI AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  33 Distinct Subtypes of Hepatorenal Syndrome and Associated Outcomes as Identified by Machine Learning Consensus Clustering AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  32 Disease Modifying Anti-Rheumatic Drugs As a Cause of IgA Nephropathy AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  31 Serum Lactate at Presentation and Acute Kidney Injury in Intermediate and High Risk Pulmonary Embolism Presenting at an Academic Tertiary Care Center AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  30 Cancer-Associated TMA AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  29 Lifesaving Molecular Adsorbent Recirculating System Use in a Young Female With Unintentional Liver Failure AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  28 An Interesting Case of Anti-Glomerular Basement Membrane Disease Mediated by IgA Autoantibodies AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  27 In Vitro Drug Interaction Studies of UNI-494 Indicate Low Risk of Drug-Drug Interactions AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  26 UNI-494 Lowers Urine Beta-2-microglobulin in Rats AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  25 Immune Complex Mediated Proliferative Glomerulonephritis Associated With Avelumab and COVID-19 Infection AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  24 A Case of Chronic Interstitial Nephritis From an Infiltrative Renal B-cell Lymphoma AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  23 Improving Post-AKI Care: A QI Approach AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  22 Cystatin C as an Early Marker of Kidney Recovery in a Patient With AKI and Rhabdomyolysis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  21 Four-Year Account of Renal and Mortality Outcomes After Elective Discontinuation of Long-Term RAAS Blockade in CKD Patients With Otherwise Inexplicable Progressive New-Onset Acute Kidney Injury AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  20 A Reduction in Serum Creatinine of at Least 30% Leads to Meaningful Clinical Outcomes in Patients with Hepatorenal Syndrome Type 1: A Pooled Analysis of 3 Phase III Studies AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  19 Risk Factors for Acute Kidney Injury (AKI) Requiring Dialysis in Patients With and Without Chronic Kidney Disease (CKD), During an Admission for Pneumonia Using a Nationally Representative Sample AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  127 There is a Blood Leak in the CRRT? AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  126 Urine Organic Acid Testing, Exposing an Unexpected Gap AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  125 A Case of Thin Basement Membrane Nephropathy Presenting With Secondary FSGS AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  124 Newly Diagnosed Renal Sarcoidosis in a Young Male AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  123 Interstitial Nephritis following Tislelizumab: A Case Report AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  122 An Atypical Presentation of AA Amyloidosis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  121 Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits in a Young Female AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  120 Central Retinal Vein Occlusion in a Patient with Biopsy Proven C3GN AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  119 Refractory Hypercalcemia: The Role of Rapid Correction Through Hemodialysis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  118 Hydralazine-Induced Full House Pattern Glomerulonephritis in a Kidney Transplant Recipient AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  117 Don't Know Why I'm So Tired: Intravenous Iron Replacement A Recipe For Persistent Hypophosphatemia AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  116 Hereditary Angiopathy with Nephropathy, Aneurysms and Muscle Cramps (HANAC) Syndrome in a Patient with Polycystic Kidney Disease AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  115 Renal Atheroembolic Disease Mimicking Interstitial Nephritis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  114 Encephalopathy Due To Baclofen in End Stage Renal Disease AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  113 Early Onset Adulthood PR3 ANCA Vasculitis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  112 Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits, IgG3 Lambda: No Age Is "Immune" AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  111 Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits: A Case Report AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  110 IgA Nephropathy With c-ANCA Positivity in a Patient With Crohn's Disease AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  109 A Case of Acquired Thrombotic Thrombocytopenic Purpura Following Near-Drowning AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  108 Pre-bariatric Surgery Acute Kidney Injury: Can This Be Prevented? AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  107 Tacrolimus Toxicity in the Setting of Novel KRAS Inhibitor, Adagrasib AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  106 HIVICK Presenting With Malignant Hypertension AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  105 Proximal Renal Tubular Acidosis and Nephrolithiasis in Pregnancy Due to SLC34A1 Gene Mutation AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  104 Silent Presentation of IgG4-Related Disease in a Chronic Kidney Disease Patient: A Case Report AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  103 Acute Pancreatitis in a Patient With Malignancy-Induced Hypercalcemia AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  102 Isolated Glycosuria in a Patient With Confirmed SLC5A2 Mutation AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  101 Sporadic Polyarteritis Nodosa Presenting With Ileal Perforation AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  100 Anticoagulant-Related Nephropathy Associated With Atypical ANCA AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  99 Histological and Clinical Anti-GBM Disease With MPO-ANCA but Without Circulating Anti-GBM Antibodies AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  98 Cocaine Induced Acute Kidney Injury From Two Possible Causes: A Case Report AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  97 An Uncommon Morphology of Intratubular Light Chain Casts in Multiple Myeloma: Amyloid Cast Nephropathy AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  96 Granulomatous Interstitial Nephritis in a Transplant Patient With Crohn’s Disease AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  95 The Transition From PD to Home Hemodialysis at Hospital Discharge AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  94 Atypical Hemolytic Uremic Syndrome From Recent Oral Contraceptive Use AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  93 Membranoproliferative Glomerulonephritis With Prostate Cancer: A Rare Paraneopalstic Nephropathy AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  92 What's My Metformin Formin'?: A Rare Case of Metformin Associated Lactic Acidosis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  91 Beckwith Weideman Syndrome and Renal Cysts: A Case Report AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  90 Characterisitc Urine Sediment in Babesia Induced AIN AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  89 A Case of Hemolytic Uremic Syndrome in a Pregnant Woman Requiring Hemodialysis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  88 Dialysis-Associated Acute Hypersensitivity During Continuous Renal Replacement Therapy and Hemodialysis: A Case Report AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  87 Minimal Change Disease Caused by Alectinib, Never Reported Side Effect of a Novel Agent AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  86 A Unique and Challenging Case of Light Chain Nephropathy With Direct Plasma Cell Infiltration of Renal Tissue AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  85 A Case of C1q Nephropathy Without Co-Deposition of Immunoglobulin G and Free Light Chains AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  84 Acute Kidney Injury in a patient With Metastatic Renal Cell Carcinoma Treated With One Dose of Nivolumab: Case report AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  83 Viral Reactivation After HCV-Positive Renal Allograft Transplantation AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  82 Chronic Hepatitis-C Infection and Kidney Failure AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  81 Collapsing Glomerulopathy From Methamphetamine Use AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  80 Gestational Diabetes Insipidus-Induced Refractory Hypokalemia AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  79 Rare Cause of Pseudotumor Cerebri Syndrome (PTS) AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  78 A Rare Case of Renal Limited Post-Transplant Lymphoproliferative Disorder (PTLD) AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  77 Triphasic Dysnatremia After Neurosurgery AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  76 Trabectedin Associated Acute Kidney Injury: A Two Person Case Series AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  75 Paxlovid-Induced Tacrolimus Toxicity in Kidney Transplant Recipients AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  74 Dance Between IgA Vasculitis and Granulomatosis With Polyangiitis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  73 Membranous Nephropathy Secondary to Autoimmune Polyglandular Syndrome AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  72 Early Plasmapheresis: A Viable Treatment Option for Hypertriglyceridemia Induced Acute Pancreatitis in a Pregnant Woman AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  180 Blood Transfusion and Transplant Rates Among Medicare Patients With Dialysis-Dependent CKD and Hyporesponse to ESAs AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  179 Inpatient Admission and Mortality Rates Among Medicare Patients With Dialysis-Dependent CKD and Hyporesponse to ESAs AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  178 The Unexpected Guest: CMV Retinitis Without Viremia in a Kidney Transplant Recipient AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  177 Atypical NF1 Diagnosis With Renal Specific Genetic Testing in a Case of Secondary Focal Segmental Glomerulosclerosis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  176 Pauci-Immune ANCA-Positive Crescentic Glomerulonephritis Associated With Metastastatic Clear Cell Ovarian Carcinoma AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  175 Rasburicase Induced Hemolytic Anemia AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  174 Left Renal Vein Entrapment Syndrome (LRVES) AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  173 AL Amyloidosis Presenting as Asymptomatic Nephrotic Range Proteinuria in a Patient With Long Standing Diabetes Mellitus AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  172 Not All Those Kidney Cysts are From ADPKD AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  171 Crescentic Lupus Nephritis With Positive Anti-MPO Antibodies in a Patient With Latent Tuberculosis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  170 Radiation Induced Baroreceptor Failure: Importance of Telehealth Blood Pressure Monitoring AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  169 Minimal Change Disease Following Novel COVID-19 Infection: Case Report and Review of Literature AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  168 Victory With Voclosporin: A Case of Complete Remission in Severe Lupus Nephritis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  167 SARS-CoV-2 as a Possible Cause of Persistent Hypophosphatemia in a Patient With End Stage Renal Disease AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  166 Role for Calcineurin Inhibitor in Tyrosine Kinase Inhibitor-Induced Focal Segmental Glomerulosclerosis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  165 Malignant Hypertension Induced Thrombotic Microangiopathy AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  164 Paraplegia and Hemodialysis Disequilibrium Syndrome AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  163 Lupus like Presentation of Acute Parvovirus B19 Infection With Hypocomplementemia in a Kidney Transplant Recipient AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  162 Successful Pregnancies in a Renal Transplant Recipient With Recurring Intrahepatic Cholestasis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  161 Daratumumab Management of Monoclonal Immunoglobulin Deposition Disease (MIDD) in a Second Renal Allograft AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  160 Coexistent Multiple Viremias and Acute Cellular Rejection in a Kidney Transplant Recipient AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  159 Crescent Formation: From Fibrillary GN, ANCA-Vasculitis, or Both? AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  158 EBV-Negative Monomorphic Post-Transplant Lymphoproliferative Disorder Associated With Hemophagocytic Lymphohistiocytosis in an Adult Kidney Transplant Recipient AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  157 Hypertensive Emergency in a Young Male: Unmasking Silent IgA Nephropathy AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  156 Linaclotide Induced Oxalate Nephropathy AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  155 Tertiary Hyperparathyroidism With Lateralization After Remote Serial Parathyroidectomies With Sequential Autotransplantation AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  154 Can Belatacept-Based Regimen Hold the Key to Successful Kidney Transplantation in Patients With Familial Lecithin-Cholesterol Acyltransferase Deficiency Nephropathy? AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  153 Recurrent Collagenofibrotic Glomerulopathy in a Kidney Transplant Recipient AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  152 More Than the Tip of the Problem AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  151 A Case of nephrocentric IgG4-related Kidney Disease AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  150 APOL-1 Kidney Disease Presenting With Advanced Uremic Chromhidrosis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  149 An Unusual Cause of Renal Amyloidosis: Skin Popping to Renal Failure AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  148 A Unique Case of Targeted Therapy Causing Immune Complex Glomerulonephritis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  147 “Keep Your Eyes Open”: A Case of Recurrent Calciphylaxis Post Kidney Transplant AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  146 Genetic Testing: Complementary or Contradictory to Kidney Biopsy in Evaluation of Patients with Chronic Kidney Disease– A Unique Case AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  145 A Case of Rituximab Rescue Therapy in Class V Lupus Nephritis With Severe Hematological Manifestations AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  144 A Case of Combined Diabetic Ketoacidosis and Lower Limb Amputation in a Patient on SGLT2-Inhibitors AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  143 Is Meso- American Nephropathy (MeN) Only a Disease of Central America? Reporting a Case Series of MeN in Trenton, NJ AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  142 A Case of Hydralazine Induced Severe Renal-Limited ANCA Vasculitis Leading to ESRD in a 63-Year-Old Man AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  141 Covid Induced Rhabdomyolysis Causing Acute Renal Failure and Transaminitis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  140 A Rare Case of Proliferative ANCA-Negative Pauci-Immune Crescentic Glomerulonephritis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  139 Hyperoxaluria Due to Moonshine Ingestion AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  138 Empyema: An Uncommon Cause for Infection-Related Glomerulonephritis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  137 In Vitro Fertilization-Related Renal Failure AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  136 Malignant Hypertension Induced Thrombotic Microangiopathy in a Patient with Primary Hyperaldosteronism AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  135 Calciphylaxis in a Non-Dialysis Chronic Kidney Disease Patient AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  134 Idiopathic Mixed Cryoglobulinemia With Renal Involvement AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  133 An Unusual Case of Fanconi-like Syndrome With Abiraterone AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  132 Resistant Hypertension Secondary to Catecholamine-Secreting Glomus Tumor AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  131 Importance of MAP Reduction for AKI Induction in Type 1 Cardiorenal Syndrome AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  130 Baclofen Toxicity Causing Delirium and Agitation in a Patient With ESRD AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  129 Minimal Change Disease Flare After COVID-19 Infection Requiring Dialysis Support AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  128 Anti-GBM Disease Presenting as Obstructive Uropathy AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  242 Assessing Chronic Kidney Disease Knowledge, Beliefs, and Risk Among Detroit Residents AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  241 Dementia Knowledge Among Multidisciplinary U.S. Dialysis Care Providers AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  240 Communication Climate Among African American Hemodialysis Patients AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  239 COVID Vaccine Hesitancy and Health Locus of Control in Inner-City Patients With Kidney Disease AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  238 Projected Annual Reductions in Central Venous Catheter (CVC)-Related S. aureus Bloodstream Infections (SA-BSIs) and Healthcare Costs (HCs) Associated With SA Nasal Decolonization (SA-ND) in SA Nares Colonized Hemodialysis Patients (SA-NC HD Pts) AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  237 Transient Hepatitis B Surface Antigenemia Following Hepatitis B Immunization: Lessons From a Recent Case AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  236 Prevalence of Housing Insecurity and Mortality Among U.S. Veterans With Kidney Failure AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  235 Collective Impact Approach to Improve CKD diagnosis and management: A Show Me CKDintercept Initiative AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  234 Patterns of ‘High-Potency Low-Cost’ NSAID Analgesic Powder Purchasing in the U.S AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  233 Effects of SARS-CoV-2 Vaccination on the Severity of COVID-19 Infection in Patients on Chronic Dialysis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  232 Barriers and Facilitators to Implementation of the End-Stage Kidney Disease Life Plan AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  231 Dialysis Care Team Communication Quality by Patient English Proficiency Status AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  230 eGFR Changes During Pegloticase Treatment With and Without Methotrexate Co-therapy: 12-month Findings of MIRROR RCT AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  229 SARS-CoV-2 Reinfection Among Maintenance Dialysis Patients: Report of 471 cases AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  228 Self-reported Eating Problems Among Patients With Chronic Kidney Disease are Associated With Higher Mortality AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  227 Association of Vaccine-induced Serum IgG Antibody and SARS-CoV-2 Infection and Hospitalization/Death Among Dialysis Patients During Omicron Era AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  226 Nephrology Providers’ Perspectives on Terminology Used to Discuss the Option of Forgoing Kidney Replacement Therapy With Patients AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  225 Success of Online CME on Knowledge of CKD-aP AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  224 Self-Reported Physical Activity Among Individuals With Chronic Kidney Disease is Associated With Greater Survival AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  223 Emergency-Only Dialysis and the Impact of Transition to Scheduled Treatment on Patient-Centered Outcomes AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  222 Short-Term Effects of Hemodynamic Instability During Hemodialysis on Cognitive Function Among Hospitalized Patients AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  221 Management of End-Stage Kidney Disease Patients Receiving Emergency Only Hemodialysis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  220 Professional Fulfillment and Burnout among Multidisciplinary U.S. Dialysis Providers AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  219 Comparative Effectiveness of Two Different Intradialytic Intervention Programs for Improving Gait and Balance in Individuals Receiving Hemodialysis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  218 Assisted Home Hemodialysis Program: A Unique Experience from the State of Qatar AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  217 Patterns of Engagement With Primary Care Services in Patients With ESKD AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  216 Stable and Adherent Patients Receiving Hemodialysis, as Compared to High-Risk Patients, Report Better Quality of Life AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  215 Dialysis Procedure Increases the Risk for Developing Substance Use Disorder in Chronic Kidney Disease Patients AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  214 AquaBplus Double Stage Water Purification System and Water Quality in Hemodialysis Clinics AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  213 Pregnancy and Family Planning in Women With Kidney Disease AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  212 Short-Term Cost Impact of Dapagliflozin in Chronic Kidney Disease AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  211 Factors Influencing the Attainment of Self-Management Goals Among Underserved Patients Living With or At-Risk for Chronic Kidney Disease (CKD) AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  210 Community Initiative to Co-Develop Chronic Kidney Disease Educational Materials for Underserved Latine Adults AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  209 Contrast-Induced Encephalopathy in Patients With CKD and ESKD: A Systematic Review AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  208 Impacts of Broad Panel Genetic Testing on the Management of Patients With Chronic Kidney Disease AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  207 Proact 1 and 2 Phase 3 Study Design: Randomized Controlled Studies of REACT in Participants With Type 2 Diabetes and Chronic Kidney Disease AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  206 Care Practices for Patients Who Forgo Kidney Replacement Therapy: A National Survey of US Nephrology Providers AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  205 Predicting Hyperkalemia in Patients With Advanced Chronic Kidney Disease Using XGBoost Model AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  204 Association of CKDaP With Sleep, Depression, and Missed Sessions Among Patients on HD AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  203 Assessment and Correlation of Pruritus Scales Among Chronic In-Center Hemodialysis Patients AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  202 The Virtual NephroTalk Experience: Learning Communication Skills During the COVID-19 Pandemic AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  201 T Wave Characteristics is the Most Sensitive ECG Change in Chronic Hemodialysis Patients AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  200 Circadian Clock Protein Rev-Erb? as a Novel Target in CKD AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  199 A Statewide Approach to Chronic Kidney Disease Prevention and Management AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  198 Renal Dysfunction in a Patient With Alstrom Syndrome AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  197 Ob-Gyn Care, Reproductive Health Education and Lack of Knowledge in Inner-City Patients With Kidney Disease AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  196 Longitudinal Homoral Response to SARS-CoV-2 immunization Among ESRD pts on HD in a NYC Public Hospital AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  195 Association of Financial Stressors with Medication Non-Adherence in Inner-City Patients With ESKD AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  194 Efficacy and Safety of Lumasiran in Patients with Primary Hyperoxaluria Type 1: 36-Month Analysis of the ILLUMINATE-A Trial AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  193 Evaluation of Changes in Serum FGF23 With Tenapanor Treatment in Patients With CKD on Dialysis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  192 Serum Phosphorus Management in Hemodialysis (HD) Patients Who Initiated Sucroferric Oxyhydroxide (SO) as a First-line Phosphate Binder Within the First Year of HD AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  191 Hypercalcemia in Peritoneal Dialysis Patient: Management Quandaries AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  190 Cardiorenal Syndrome: CKD, Heart Failure and Risk for Dementia AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  189 Background Rates of Selected Cardiovascular (CV) Events in Non-Dialysis (ND) Patients With CKD-Related Anemia Receiving Erythropoietin-Stimulating Agents (ESAs) in the United States (US) AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  188 Background Rates of Selected Cardiovascular (CV) Events in Dialysis-Dependent (DD) Patients in the United States (US) AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  187 The Effects of Unconjugated p-Cresol v. p-Cresol Sulfate on Macrophage Uptake of Modified LDL AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  186 Chronic Kidney Disease and Anemia Questionnaire (CKD-AQ), a New Patient-Reported Outcomes (PRO) Measure Developed for Use in Patients With Anemia of CKD AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  185 Allograft Nephrectomy: A Management for Erythropoiesis-Stimulating Agent-Resistant Anemia in A Patient With A Failed Kidney Transplant AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  184 DISC-0974, an Anti-Hemojuvelin Antibody, Reduces Hepcidin and Mobilizes Iron in Healthy Volunteers AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  183 The Effects of Daprodustat on Blood Transfusion Rates in the ASCEND-D and -ND Trials AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  182 Red Blood Cell (RBC) Transfusion Use Varies By Baseline Hemoglobin (Hb) and Is Associated With Post-Transfusion Hyperkalemia and Hospitalization Within 30 Days in US Patients With Stage 3–5 CKD and Anemia AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  181 Protocol for the Erythropoiesis via a Novel PHI Daprodustat: Pediatric (ASCEND-P) Trial AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  303 Success Story of a Challenging Case of Refractory Lupus Nephritis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  302 Repeat Kidney Biopsies in ANCA-associated Vasculitis: Clinical and Histologic Progression AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  301 The Association Between Surrogate Kidney Endpoints and Hard Clinical Outcomes in IgA Nephropathy: A Systematic Literature Review AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  300 Determinants of Serum Potassium Levels in Patients With Chronic Kidney Disease AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  299 Comparison of Oral Potassium Binders in Acute Hyperkalemia AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  298 Sodium Correction Rate and Clinical Parameters of Patients Treated With Proactive DDAVP Clamp for Hyponatremia: A Case Series AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  297 The Safety and Efficacy of Vaptans in the Treatment of Hyponatremia from Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): A Systematic Review and Meta-Analysis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  296 Potassium Binders: A Systematic Review and Network Meta-Analysis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  295 Management of Severe Hyponatremia With Modified CVVHDF AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  294 Hypomagnesemia, Renal Cysts and Uterine Agenesis due to Hepatocyte Nuclear Factor 1Beta (HNF1ß) Mutation AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  293 Extreme Hypernatremia With Masked Partial Nephrogenic Diabetes Insipidus Due to Chronic Lithium Use AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  292 Recurrence of Hyperkalemia Following Dietary Counseling, REVOLUTIONIZE I Real-World Evidence Study AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  291 Severe Hypokalemia in a Congenital Distal Renal Tubular Acidosis Case AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  290 Idiopathic Renal Phosphaturia With Incidental Finding of NPHS2 Mutation AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  289 Diagnosis and Management of Patients With Hyponatremia in the First 24 Hours Following Emergency Department Admission AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  288 Hypokalemia and Polyuria: Not Always an Occam's Razor AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  287 Improving Knowledge, Competence, and Confidence of Nephrologists and Primary Care Providers Related to Hyperkalemia With Curriculum-Based Online Education AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  286 Case-Based, Online CME Successful at Improving Management of Hyperkalemia AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  285 Renal Magnesium Wasting Post COVID-19 Infection: A Possible Unrecognized Cause of Hypomagnesemia AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  284 Check Point Inhibitor Induced Hyponatremia: A New Player Into Hyponatremia Differential Diagnosis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  283 Immune Checkpoint Inhibitor-induced Renal Tubular Acidosis and Nephrocalcinosis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  282 Hyponatremia of Cholestatic Liver Disease: ‘True' or ‘Pseudo' AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  281 Medical Costs in Patients With Hyperkalemia on Long-Term Sodium Zirconium Cyclosilicate Therapy: RECOGNIZE II Study AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  280 Impact of Sodium Zirconium Cyclosilicate Plus Renin-Angiotensin-Aldosterone System Inhibitor Therapy on Short-Term Medical Costs In Hyperkalemia: OPTIMIZE II Study AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  279 A Peculiar Case of Pseudohypobicarbonatemia AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  278 RAASi Optimization Among Patients Initiating SZC, OPTIMIZE I RWE Study AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  277 Higher Risk of Progression to Albuminuria in Asian and Pacific Islander Adults With Diabetes AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  276 The Effect of Sodium-Glucose Cotransporter 2 Inhibitors, Mineralocorticoid Receptor Antagonists, and Its Combination On Albuminuria in Patients With Diabetic Nephropathy AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  275 Improving Care in Diabetic Kidney Disease: Bridging the Implementation Gap AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  274 Impact of KidneyIntelX Testing on Novel Medication Prescription in a Diverse Patient Population AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  273 Comparative Levels of Urinary Biomarkers of Renal Injury and Inflammation Among Patients With Diabetic Nephropathy With or Without Hyperuricemia AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  272 Monitoring Arterial-Venous Fistula Patency Using Artificial Intelligence AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  271 Ischemic Monomelic Neuropathy AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  270 Wearable Device for Continuous, Non-Invasive Monitoring of Access Patency in Hemodialysis Patients AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  269 BRAG: When Does an A-V Access Need a Closer Look? AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  268 Long-Term Outcomes of Stent Grafts in Managing Thrombosed Thigh Arteriovenous Grafts AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  267 Mechanical Neobladder Dysfunction and Subclinical Pyelonephritis are the Most Common Causes of Progressive Chronic Kidney Disease After Ileal Neobladder Substitution AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  266 Race and the 2021 CKD-EPI Equations AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  265 8-Year Effects of Lifestyle Intervention on Kidney Outcomes Adjusting for Time-Updated Lean Mass AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  264 Diabetic Kidney Disease Epidemiology in US Veterans AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  263 Impact of Online CME on Knowledge of Link Between Hemodialysis and Pruritus in Patients With CKD AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  262 Current Kidney Failure Awareness and Risk Factor Control in the US Population AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  261 Association Between Spirituality and Beliefs in Medicine in a Population of Inner-City Patients with CKD/ESKD AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  260 Patiromer-Facilitated Mineralocorticoid Receptor Antagonist Use in Patients With Heart Failure and eGFR AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  259 Patient and Clinician Perspectives on the Value of Kidney Biopsies AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  258 Cancer Screening Rates in Patients With Kidney Failure on Hemodialysis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  257 Time to Improvement of Itch Intensity in Patients With Chronic Kidney Disease-Associated Pruritus Treated With Difelikefalin AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  256 Lanthanum When Swallowed, Not Chewed: An Emergency Department Visit and Clinical Findings AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  255 Knowledge of Chronic Kidney Disease in Medical Providers and Its Impact on the Healthcare System AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  254 Characteristics of Finerenone Initiators Among Patients With Chronic Kidney Disease (CKD) and Type 2 Diabetes (T2D) AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  253 Post-COVID Syndrome-Associated Oxidative Stress in Hemodialysis Patients AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  252 Renal Autologous Cell Therapy (REACT) for Diabetic Chronic Kidney Disease: Phase II Trial with Bilateral Injections and Re-Dosing Triggers AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  251 Precision Medicine in Nephrology: The Role of Genetic Testing AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  250 Post Hoc Analyses of Serum Phosphate Changes With Tenapanor in Black/African American and White Patients on Maintenance Dialysis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  249 An In-Depth Analysis of Serum Phosphate Changes in Patients With CKD on Dialysis: Results From the PHREEDOM Study AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  248 Binder Weight to Bind 1 Gram of Phosphate AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  247 Background Rates of Selected Non-Cardiovascular (CV) Events in Non-Dialysis (ND) Patients With Chronic Kidney Disease (CKD)-Related Anemia Receiving Erythropoiesis-Stimulating Agents (ESAs) in the United States (US) AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  246 Background Rates of Selected Non-Cardiovascular (non-CV) Events of Interest in Dialysis-Dependent (DD) Patients in the United States (US) AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  245 Novel Renal Autologous Cell Therapy (REACT) for Chronic Kidney Disease With Diabetes (DKD): Investigative Trial Experience in Mississippi AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  244 Kidney Failure Treatment Options and Shared Decision-Making by Ethnic Chinese: A Scoping Review AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  243 Simplified and Improved Patient Education in Chronic Kidney Disease - Medication and Disease Management: The “YOU” Project AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  365 Clinical Outcomes of Peritoneal Dialysis in Patients With Chronic Liver and Kidney Failure: A Single-Center Experience AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  364 Redefining Dialysis Care on the Hawaiian Islands: Reducing Health Disparities and Resource Utilization AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  363 Outcomes in Critical Care Admissions in Peritoneal Dialysis Patients AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  362 Trends in Critical Care Admissions in Peritoneal Dialysis Patients AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  361 The NxStage Hemodialysis Filter Rotator for Anticoagulation-Free Hemodialysis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  360 CAPD a Good Choice for Many; Can the Culture of APD be Changed? AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  359 Home Therapies During the COVID-19 Pandemic in an Urban US Population AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  358 Sodium Thiosulfate in Peritoneal Dialysis Patients With Calciphylaxis: A Systematic Review AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  357 Achromobacter Xyxlosoxidans Peritonitis After Open Contamination in a Peritoneal Dialysis Patient AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  356 Analysis of Lost Dwell Time and Cycler Alarms in Inpatient Automated Peritoneal Dialysis at a Tertiary Care Hospital AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  355 Providers Can Leverage Home Hemodialysis to Reduce Total Cost of Care in Risk-based Contracts with Medicare Advantage Organizations AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  354 Home Hemodialysis Can Help Reduce Total Cost of Care Among Medicare Advantage Members With ESRD AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  353 Variables Impacting Home Dialysis Utilization Among AKF Financial Assistance Recipients AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  352 Qualitative Analysis of People With APOL1-Mediated Kidney Disease Highlights Need for Patient-Centered Educational Resources AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  351 Diagnostic Utility of Broad-Based Renal Genetic Testing in Patients With Dent Disease AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  350 Genetic Testing for Isolated Hematuria Catalyzes Management and Cascade Testing for X-linked Alport Syndrome AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  349 Increased Imaging Burden in Patients with Autosomal Dominant Polycystic Kidney Disease AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  348 Tesevatinib (KD019) vs Placebo for ADPKD: Results of a Ph2b Trial AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  347 Disease Burden and Disease Progression of Young Adult Patients With Autosomal Dominant Polycystic Kidney Disease AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  346 Post-marketing Liver Safety Data from 4 Years of the Tolvaptan Risk Evaluation and Mitigation Strategy (REMS) in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  345 Mortality of Peritoneal Dialysis Patients With Liver Cirrhosis: A Systematic Review and Meta-Analysis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  344 Unexpected Discoveries of Townes-Brocks Syndrome Revealed by Broad Kidney Gene Panel Testing AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  343 Autosomal Recessive Alport Syndrome With Pathogenic Variants AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  342 Bilateral Kidney Cysts and Neurodevelopmental Disorder: A Young Female With De Novo Pathogenic Variant in the NR4A2 Gene AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  341 The Impact of Genetic Test Results on Kidney Disease Diagnosis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  340 An Unusual Case of Rapidly Progressing Polycystic Kidney Disease AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  339 Hypokalemic Hypomagnesemia in an Adult Presenting With Arrhythmia: Gitelman Syndrome? AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  338 Long-Term Sparsentan Treatment in FSGS in the DUET Open-Label Extension (OLE) AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  337 ANCA-associated Necrotizing and Crescentic Glomerulonephritis Linked to Immune Checkpoint Inhibitor Durvalumab AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  336 Lenvatinib-induced Cryoglobulinemic Glomerulonephritis: It Is Never Too Late AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  335 A Case of Glomerulonephritis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  334 An Atypical Case of Seronegative Anti-GBM Disease and Concomitant IgA Nephropathy AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  333 Single Doses of Iptacopan Treatment Quickly Decreases Plasma Complement Bb Levels AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  332 Pharmacokinetics of Single Doses of Iptacopan AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  331 Alternative Therapy for Refractory PGNMID AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  330 Voclosporin Inhibits Calcineurin and T Cell Activation at Dose Levels Clinically Relevant for the Treatment of Lupus Nephritis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  329 Proteinuria Reduction With Sparsentan in Immunoglobulin A Nephropathy (IgAN): PROTECT Study Interim Results AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  328 Proteinuria and Disease Progression in the RaDaR IgAN Cohort AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  327 Zetomipzomib is Associated With Clinically Meaningful Reduction of Proteinuria in LN Class III/IV With or Without Class V: Post-Hoc Analysis From the Open-Label MISSION Phase 2 Study AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  326 Lupus Nephritis With Superimposed Necrotizing and Crescentic PR-3 Antineutrophil Cytoplasmatic Antibody AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  325 Plasma Exchange as an Adjunctive Therapy for Rapidly Progressive IgA Nephropathy: A Systematic Review AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  324 Rare Presentation of Monoclonal Immunoglobulin Deposition Disease in a Young Patient AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  323 Efficacy of Extracorporeal Plasma Therapy for Adult Native Kidney Patients With Primary FSGS: A Systematic Review AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  322 Long-Term Sparsentan Treatment in Young Patients With FSGS in the DUET Open-Label Extension (OLE) AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  321 Facing the Barriers of Renal Amyloidosis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  320 Immunoglobulin A Nephropathy Patient Reported Health Utility and Quality of Life: Evidence from US Real-World Data AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  319 Assessment of Hepatic Impairment on Iptacopan Pharmacokinetics AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  318 Assessment of Drug Interactions With Iptacopan AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  317 Case of Goodpasture syndrome With Double-Positive Anti-Glomerular Basement Membrane (GBM) and Myeloperoxidase-Anti Neutrophil Cytoplasmic Antibodies (MPO-ANCA) AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  316 Rare Dual Glomerulopathy: MPO-ANCA and Secondary Membranous Nephropathy AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  315 A Case of Immune Checkpoint Inhibitor Associated PLA2R Membranous Nephropathy and Concurrent Acute Interstitial Nephritis Treated With Anti-CD20 Therapy AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  314 Collagenofibrotic Glomerulopathy AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  313 Serodiagnosis of Anti-Glomerular Basement Membrane Disease Using a Newly Developed Chemiluminescence Immunoassay AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  312 Relevance of Anti-PLA2R Levels in Therapy Decision and Prediction of Therapy Outcome Using Cyclophosphamide and Steroids Treatment in Patients With Membranous Nephropathy AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  311 A Case of Glomerulonephritis With Dual Seropositive Autoantibodies AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  310 Treatment Considerations of Anti-GBM and ANCA Overlap Syndrome: First Do No Harm AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  309 Simultaneous Presence of MPO-ANCA Vasculitis and A Lymphoplasmacytic Lymphoma Isolated to the Bowman’s Capsule Requiring a Multidisciplinary Approach to Treatment AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  308 Primary Membranous Nephropathy Shortly After COVID-19 Vaccination AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  307 Pipeline Innovation in Glomerular Diseases AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  306 Enlight-LN: A Prospective Observational Registry of Patients Treated With Voclosporin for Lupus Nephritis in the United States AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  305 Trial in Progress: Voclosporin in Adolescents With Lupus Nephritis (VOCAL) AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  304 A Case of Podocytic Infolding Glomerulopathy: A Pattern of Injury AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  431 Acetaminophen as a Renoprotective Treatment in Severe Malaria AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  430 AL Amyloidosis: Kidney Edition AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  429 Learner Perceptions of Kidney Physiology Demonstrated Through the Flipped Classroom (FC) Design for Second Year Medical Students (MS2), the University of Cincinnati Experience AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  428 Race- and Gender-Free Equation to Estimate Kidney Function in Transgender Adults AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  427 Educating Nurses on the Progression of Chronic Kidney Disease AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  426 Disparities of Care Continue to Exist Even After Removing Race From the eGFR Calculation AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  425 ActivatEd: Activating Patients With Video Education AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  424 Kidney Biopsy Findings in Loin Pain Hematuria Syndrome in Kidney Autotransplant Patients AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  423 Case of Heterozygous Variant of SLC2A9 Causing Urate Nephropathy AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  422 Advanced Practice Provider Nephrology Fellowship AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  421 Whole Body Phase Angle and Body Composition and Relationship to Frailty in Kidney Transplant Recipients (KTRs) AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  420 Racial Disparity and Hypertension in Living Kidney Donors AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  419 Distinct Phenotypes of Dual Kidney Transplant Recipients in the United States as Identified Through Machine Learning Consensus Clustering AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  418 Post-Renal Acute Kidney Injury: An Overlooked Cause of Allograft Dysfunction in a Kidney Transplant Recipient AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  417 Successful Outcomes in Post-Transplant Thrombotic Microangiopathy With Novel Immunosuppression Strategy AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  416 NMR-based GFR Estimating Equation in Kidney Transplant Recipients Bias and Precision AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  415 The Transplant Experience for Undocumented Immigrants Formerly Receiving Emergency-Only Dialysis AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  414 A Case Report of Recurrent C3 Glomerulonephritis Post-COVID Infection and Vaccination AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  413 Characteristics of Kidney Recipients of High Kidney Donor Profile Index Kidneys as Identified by Machine Learning Consensus Clustering AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  412 A Case of Transplant vs Transfusion-associated Graft vs Host Disease AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  411 Donor-Derived Strongyloides Stercolis Infection in a Kidney Transplant Recipient AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  410 Racial and Ethnic Differences in Inpatient Mortality in Kidney Transplant Recipients with COVID-19 Infection: a Nationally Representative Study AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  409 Renal Transplant Transition Rates After Neurocognitive Evaluation in ESRD AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  408 Knowledge and Attitudes of Health Care Professionals in the Intensive Care Unit (ICU), Haemodialysis Unit (HDU), and Accident and Emergency Department (A&E) at a Teaching Hospital Toward Organ (Kidney) Donation and Transplantation AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  407 Monosodium Urate Crystal Depletion in Renal Transplant Recipients Treated With Pegloticase: PROTECT Serial Dual-Energy Computed Tomography Findings AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  406 Malakoplakia: A Case Report of a Rare Granulomatous Condition Afflicting a Renal Transplant Recipient AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  405 Cytomegalovirus Gastroparesis After Kidney Transplantation: A Case Report AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  404 2, 8 Dihydroxyadenine Kidney Allograft Crystallopathy Recurrence in Kidney Transplantation AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  403 Curious Case of Acute Interstitial Nephritis in Kidney Transplant: Association With Red Meat Allergy? AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  402 The Curious Case of Lung Mass in a Renal Transplant Recipient AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  401 Successful Treatment of Thrombotic Microangiopathy Due to Acute Antibody Mediated Rejection of Kidney Transplant AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  400 Belatacept Based Immunosuppression in Patient With Combined Heart and Kidney Transplant: A Case Report AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  399 Double Trouble: Recurrence of Membranous Nephropathy in a Liver-Kidney Transplant Patient AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  398 Effect of Overhydration in Energy Expenditure in Chronic Kidney Disease AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  397 Evaluating Dietitian Implementation of Renal Nutrition Guideline Recommendations AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  396 Home-Delivered Meal Engagement Among Hemodialysis Patients in the Denver Metro AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  395 Effectiveness of Short-term, Home-delivered, Low Sodium Meals to Sustain Long-term Changes in Dietary Behavior in Hemodialysis Patients AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  394 Changes in Gut-Derived Uremic Toxins With Dietary CKD Counseling AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  393 Impact of Intra-Dialytic Meals During In-Center Hemodialysis Treatment on Depressive Symptoms: Findings From the FrEDI Randomized Controlled Trial AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  392 Effect of Vitamin D Supplementation on Dialysis Patients' Serum Vitamin D Levels: Systematic Review AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))
• 10:30
  391 Correlation between physical function and physical activity with muscle mass measured with computed tomography in adults’ hemodialysis patients AJKD
  (American Journal of Kidney Diseases 81, 4 (2023))